BridgeMD
New treatment option for Rheumatoid Arthritis (RA)
Official title Medical Device for Sustained Remission in Rheumatoid Arthritis Treated With Biological Therapy
ClinicalTrials.gov ID: NCT07678112
What this study is testing
- What it's testing
- This study aims to evaluate a new tool designed to help doctors decide whether it is safe to reduce medication in patients with rheumatoid arthritis (RA) who are in remission. Rheumatoid arthritis is a chronic inflammatory disease that affects the joints, causing pain, stiffness, and reduced mobility.
- Time commitment: about 12 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged ≥18 years.
- Diagnosis of rheumatoid arthritis according to either the 1987 American College of Rheumatology (ACR) criteria or the 2010 ACR/EULAR classification...
- Clinical remission for at least 6 months prior to the baseline visit, defined as DAS28-CRP \< 2.6.
- Receiving biological anti-TNF therapy (infliximab, adalimumab, etanercept, golimumab, or certolizumab).
- Ability and willingness to provide written informed consent to participate in the study.
You likely can't join if
- Patients in whom biological therapy was prescribed due to systemic manifestations of rheumatoid arthritis.
- Patients with rheumatoid arthritis and any known associated condition that may interfere with the assessment of study outcomes (e.g., fibromyalgia or...
- Patients receiving chronic anti-TNF biological therapy who are already undergoing treatment tapering or are on reduced or extended dosing regimens...
The study team makes the final eligibility decision.
Where it's taking place
- A Coruña, A Coruña, Spain
- Alava, Alava, Spain
- Barcelona, Barcelona, Spain
- Madrid, Madrid, Spain
- Málaga, Málaga, Spain
- San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include A Coruña, A Coruña, Spain; Alava, Alava, Spain; Barcelona, Barcelona, Spain; Madrid, Madrid, Spain; Málaga, Málaga, Spain; San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.